Wilex moves to CRO work; WuXi bags another regulatory nod;

> German biotech Wilex has effectively become a CRO after handing off its drug candidates and focusing on contract work to generate revenue. Story

> WuXi PharmaTech's ($WX) toxicology facility in Suzhou, China, has passed Belgian muster. More